Strata Critical Medical, Inc.

Strata Critical Medical, Inc. operates as a specialized logistics and medical services provider focused on time-critical organ transportation for transplant procedures across the United States. The company functions as both an air and ground transporter, moving human organs between healthcare facilities to facilitate transplant surgeries. This mission-critical service addresses a core need in the U.S. healthcare system where organ viability depends on rapid, reliable delivery from donor sites to recipient hospitals.

The company's primary revenue streams derive from its dual transportation capabilities—utilizing both air and ground networks to move organs and related medical materials. As a provider of specialized medical logistics, the company serves healthcare networks and transplant centers nationwide. The company was founded in 2014 and rebranded from Blade Air Mobility, Inc. to Strata Critical Medical, Inc. in August 2025, reflecting a strategic focus shift toward its critical medical services business.

The company operates with approximately 310 full-time employees and maintains headquarters in New York, New York. Strata Critical Medical is incorporated in Delaware and trades on the Nasdaq under ticker SRTA, with a market capitalization of $0.4 billion.